Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.
Hyle
E P
EP
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts 02114-2696, USA.
Ferraro
M J
MJ
Silver
M
M
Lee
H
H
Hooper
D C
DC
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001900:Boston / Q000453:epidemiology; D016022:Case-Control Studies; D003428:Cross Infection / Q000453:epidemiology / Q000209:etiology / Q000382:microbiology*; D024881:Drug Resistance, Bacterial; D024901:Drug Resistance, Multiple, Bacterial; D004755:Enterobacteriaceae / Q000187:drug effects / Q000302:isolation & purification*; D004756:Enterobacteriaceae Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology*; D004866:Equipment Contamination; D000077727:Ertapenem; D005260:Female; D006761:Hospitals; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D012307:Risk Factors; D016896:Treatment Outcome; D014505:Urban Population; D055815:Young Adult; D047090:beta-Lactams / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D047090:beta-Lactams; D000077727:Ertapenem